Guoyu Tong
321 Zhongshan Road
Nanjing, 210008, China
Nanjing, 210008, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Efficacy and safety of cAMP signalling-biased GLP-1 analogue ecnoglutide monotherapy versus placebo in patients with type 2 diabetes (EECOH-1): a multi-centre, randomised, double-blind, placebo-controlled, phase 3 trial.
Journal: Nature communications
Published: March 31, 2025
Effect of baseline characteristics on the efficacy of dulaglutide added to basal insulin in Chinese patients with type 2 diabetes: A subgroup analysis of AWARD-CHN3.
Journal: Diabetes, obesity & metabolism
Published: September 20, 2023
Efficacy and safety of GLP-1 analog ecnoglutide in adults with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 2 trial.
Journal: Nature communications
Published: August 02, 2023
Comparative efficacy of anti-diabetic agents on nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized and non-randomized studies.
Journal: Diabetes/metabolism research and reviews
Published: April 04, 2015
Effects of exenatide, insulin, and pioglitazone on liver fat content and body fat distributions in drug-naive subjects with type 2 diabetes.
Journal: Acta diabetologica
Published: April 03, 2014
Intensive insulin therapy increases sex hormone-binding globulin in newly diagnosed type 2 diabetic patients.
Journal: European journal of endocrinology
Published: November 07, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026